To further understand the importance of METTL5 during the progression of MM, we also assessed METTL5 expression in patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering MM (SMM), which are considered precancerous conditions of MM [1]. This evidence concerns the gene METTL5 and Miyoshi myopathy.